Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vrej, Jubian"'
Autor:
Gamini Chandrasena, J. John Mann, Jaya Prabhakaran, Mathivanan Packiarajan, Vrej Jubian, J. S. Dileep Kumar, Mali Pratap, Ramin V. Parsey, Mary W. Walker
Publikováno v:
ACS chemical neuroscience. 7(5)
Neuropeptide Y receptor type 5 (NPY5R) is a G-protein coupled receptor (GPCR) that belongs to the subfamily of neuropeptide receptors (NPYR) that mediate the action of endogenous neuropeptide Y (NPY). Animal models and preclinical studies indicate a
Autor:
Laxminarayan G. Hegde, Mary W. Walker, Vrej Jubian, Mariusz Papp, Mohammad R. Marzabadi, Douglas A. Craig, Christophe P. G. Gerald, David H. Overstreet, Silke Miller, Gamini Chandrasena, Huailing Zhong, Toni D. Wolinsky, Douglas A. Marsteller, Xinyan Huang
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 328:900-911
Neuropeptide Y (NPY) regulates physiological processes via receptor subtypes (Y1, Y2, Y4, Y5, and y6). The Y5 receptor is well known for its role in appetite. Based on expression in the limbic system, we hypothesized that the Y5 receptor might also m
Publikováno v:
Tetrahedron Letters. 36:2551-2554
In this paper we show that a thiourea-functionalized terpyridine unit can be induced to form, in the presence of ruthenium (II), a well-ordered recognition site for dicarboxylate ions. Strong binding to the self-assembled receptor can be followed by
Autor:
Lingyun Wu, Gamini Chandrasena, Vrej Jubian, Kai Lu, Toni C. Wolinsky, Mary W. Walker, Mathivanan Packiarajan
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(6)
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from screen hit 1. The dihydroindolyl glycinamide 10a significantly inhibits NPY5 agonist induced feeding at a dose of 0.1 mg/k
Autor:
Mathivanan Packiarajan, Hermogenes N. Jimenez, Mary W. Walker, Mohammad R. Marzabadi, Kim Andersen, Mahesh N. Desai, Toni C. Wolinski, Emily Reinhard, Vrej Jubian, Heather Coate, Gamini Chandrasena
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(21)
Synthesis, SAR and physico-chemical properties of an alkyl aminothiazole series 8 and 16 are described. 2-Pyridylaminothiazole based compounds such as 8c and 16a exhibit high affinity at the NPY(5) receptor with desirable cLogPs and solubilities. How
Autor:
Vrej Jubian, Noel J. Boyle, Mathivanan Packiarajan, Lingyun Wu, Amita Joshi, Mahesh N. Desai, Kai Lu, Mary W. Walker, Mohammad R. Marzabadi, Kim Andersen, Gamini Chandrasena
Publikováno v:
Bioorganicmedicinal chemistry letters. 21(18)
Subtype specific ligands are needed to evaluate the therapeutic potential of modulating the brain's neuropeptide Y system. The benzothiazepine glycinamide 1a was identified as an NPY5 antagonist lead. While having acceptable solubility, the compound
Autor:
Ove Wiborg, Mathivanan Packiarajan, Mohammad R. Marzabadi, Toni D. Wolinsky, Yalei Lu, Gamini Chandrasena, Hualing Zhong, Kim Andersen, Mary W. Walker, Wai C. Wong, Mahesh N. Desai, Vrej Jubian, Stewart A. Noble
Publikováno v:
Packiarajan, M, Marzabadi, M R, Desai, M, Lu, Y, Noble, S A, Wong, W C, Jubian, V, Chandrasena, G, Wolinsky, T D, Zhong, H, Walker, M W, Wiborg, O & Andersen, K 2011, ' Discovery of Lu AA33810 : a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder ', Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 18, pp. 5436-41 . https://doi.org/10.1016/j.bmcl.2011.06.124
The structure–activity relationship of a series of tricyclic-sulfonamide compounds 11 – 32 culminating in the discovery of N -[ trans -4-(4,5-dihydro-3,6-dithia-1-aza-benzo[e]azulen-2-ylamino)-cyclohexylmethyl]-methanesulfonamide ( 15 , Lu AA3381
Publikováno v:
ChemInform. 27
Autor:
Mary W, Walker, Toni D, Wolinsky, Vrej, Jubian, Gamini, Chandrasena, Huailing, Zhong, Xinyan, Huang, Silke, Miller, Laxminarayan G, Hegde, Douglas A, Marsteller, Mohammad R, Marzabadi, Mariusz, Papp, David H, Overstreet, Christophe P G, Gerald, Douglas A, Craig
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 328(3)
Neuropeptide Y (NPY) regulates physiological processes via receptor subtypes (Y(1), Y(2), Y(4), Y(5), and y(6)). The Y(5) receptor is well known for its role in appetite. Based on expression in the limbic system, we hypothesized that the Y(5) recepto
A family of synthetic receptors has been prepared containing a barbiturate binding site and an appended thiol nucleophile. These are shown to cause large accelerations in the thiolysis reactions of barbiturate active ester derivatives. The size of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a33c1caf801c0761d0d0dc0b314e9ced
http://hdl.handle.net/11368/2562854
http://hdl.handle.net/11368/2562854